– Data published in the Journal of Infectious Diseases demonstrate that M2SR can protect against a multi-seasonal, seven-year drifted influenza strain – MADISON, Wis., Aug. 2, 2021 /PRNewswire/ — FluGen, Inc., a… read more →
– Study is the Company’s first trial evaluating ability of M2SR and the current licensed standard of care to protect against drifted virus strains, and its second study in older… read more →
– Study will measure immune responses to matched and drifted virus strains in older adults, a population that is most vulnerable to mortality from flu – – Topline data expected… read more →
UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine April 02, 2020 12:15 PM Eastern Daylight Time MADISON, Wis.–(BUSINESS WIRE)–An international collaboration of virologists at the University of Wisconsin–Madison… read more →